• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4625941)   Today's Articles (3604)   Subscriber (49531)
For: Paparella MM, Schachern P. New developments in treating otitis media. Ann Otol Rhinol Laryngol Suppl 1994;163:7-10. [PMID: 8179274 DOI: 10.1177/00034894941030s503] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Number Cited by Other Article(s)
1
Magliulo G, Iannella G, Granata G, Ciofalo A, Pasquariello B, Angeletti D, La Marra F, Quinti I. Otologic evaluation of patients with primary antibody deficiency. Eur Arch Otorhinolaryngol 2016;273:3537-3546. [PMID: 26935054 DOI: 10.1007/s00405-016-3956-y] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2015] [Accepted: 02/26/2016] [Indexed: 12/11/2022]
2
Si Y, Zhang ZG, Chen SJ, Zheng YQ, Chen YB, Liu Y, Jiang H, Feng LQ, Huang X. Attenuated TLRs in middle ear mucosa contributes to susceptibility of chronic suppurative otitis media. Hum Immunol 2014;75:771-6. [PMID: 24882571 DOI: 10.1016/j.humimm.2014.05.009] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2013] [Revised: 05/18/2014] [Accepted: 05/18/2014] [Indexed: 11/27/2022]
3
Effect of caffeic acid phenethyl ester on myringosclerosis development in the tympanic membrane of rat. Eur Arch Otorhinolaryngol 2013;272:29-34. [DOI: 10.1007/s00405-013-2832-2] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2013] [Accepted: 11/18/2013] [Indexed: 10/26/2022]
4
Ozdemir T, Cincik H, Dogru S, Cekin IE, Ulubil SA, Gungor A. Efficacy of topical halofuginone in myringotomy patency. Eur Arch Otorhinolaryngol 2010;267:1701-4. [PMID: 20574743 DOI: 10.1007/s00405-010-1306-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2009] [Accepted: 06/07/2010] [Indexed: 11/26/2022]
5
John EO, Russell PT, Nam BH, Jinn TH, Jung TT. Concentration of nitric oxide metabolites in middle ear effusion. Int J Pediatr Otorhinolaryngol 2001;60:55-8. [PMID: 11434954 DOI: 10.1016/s0165-5876(01)00509-2] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
6
Vambutas A, Paparella MM. Tympanoplasty: prudent considerations of silent otitis media and interactions of middle ear and inner ear. Otolaryngol Clin North Am 1999;32:505-12. [PMID: 10393782 DOI: 10.1016/s0030-6665(05)70148-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
7
Jung TT, Hanson JB. Classification of otitis media and surgical principles. Otolaryngol Clin North Am 1999;32:369-83. [PMID: 10393773 DOI: 10.1016/s0030-6665(05)70139-0] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
8
Rodrigo C. Prevention of acute otitis media. Clin Microbiol Infect 1997. [DOI: 10.1016/s1198-743x(14)64955-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA